March 14- An experimental Amgen Inc cancer vaccine used to treat advanced melanoma, the deadliest form of skin cancer, proved effective in a late-stage study in shrinking tumors in a way that suggests the drug triggered the intended systemic immune response, according to data presented on Friday.» Read More
Dr. Richard Saul wrote a book called "ADHD Does Not Exist." Saul is certain attention ADHD, or attention deficit hyperactivity disorder exists only in its symptoms. The condition does not exist.
March 12- Shares of Zogenix Inc fell 14 percent after Purdue Pharma LP said it was moving ahead with an abuse-resistant rival to Zogenix's much-criticised painkiller.
March 12- Geron Corp said the U.S. Food and Drug Administration ordered a halt to trials of its cancer drug imetelstat over concerns about potential liver damage, sending the company's shares plunging almost 60 percent before the bell.
JEFFERSON CITY, Mo.-- Missouri would become the third state to make women wait three days to have an abortion after seeing a doctor under legislation passed by the state House on Tuesday. The bill would triple Missouri's current 24- hour waiting period and put the state in line with Utah and South Dakota as the only states to mandate a 72- hour time frame.
The influential American Society of Clinical Oncology, in a report released on Tuesday, cited estimates that cancer will become the leading killer in the United States by 2030 as the population ages, while treatment costs reach new heights.
March 10- Germany has granted Northwest Biotherapeutics Inc special permission to sell its experimental brain cancer drug in the country, the company said, and its stock jumped as much as 36 percent.
March 10- German health regulators have granted Northwest Biotherapeutics Inc special permission to sell its experimental brain cancer drug, DCVax-L, in the country, even though the small U.S. biotechnology company has not yet completed its late-stage trial of the immunotherapy.
March 7- The U.S. Food and Drug Administration has asked Regeneron Pharmaceuticals Inc and Sanofi SA to assess potential neurocognitive side effects of their experimental cholesterol drug, Sanofi said in its annual report on Friday.
Ranbaxy Laboratories issued a recall of generic versions of the cholesterol drug Lipitor in the U.S. because of potential dosage issues, WSJ reported.
Calling it a serious threat, the CDC says American hospitals are overprescribing antibiotics, leaving patients vulnerable to superbugs.
March 6- Endo International Plc said the U.S. Food and Drug Administration approved its thrice-rejected testosterone replacement therapy, Aveed, to treat male hypogonadism.
March 6- Endo Health Solutions Inc said the U.S. Food and Drug Administration approved its thrice-rejected testosterone drug, Aveed, to treat male hypogonadism. The health regulator rejected the drug last May, saying that Endo needed a better plan to manage the risks associated with the drug.
Surgery to remove the prostate saves lives compared to "watchful waiting" for some men whose cancers were found because they were causing symptoms, long-term results from a Scandinavian study suggest. In Europe, PSA testing is far less common, and most prostate cancers are found when they cause symptoms such as trouble urinating.
PHOENIX-- Abortion providers said Wednesday that they have sued the state of Arizona to try to block new state rules limiting the use of the most common abortion drugs. The rules released in January by the Arizona Department of Health Services are set to take effect April 1.
Data from the small study of the Sangamo BioSciences therapy, known by the code name SB-728-T, were issued in the New England Journal of Medicine, the first publication of data from a human trial of a technology called "gene editing." The Phase 1 trial, led by the University of Pennsylvania, enrolled 12 HIV patients.
Glenn Dubin, a Highbridge Capital Management, and co-founder & CEO of Dubin & Co., says the Dubin Breast Center is a mufti-disciplinary center driving for excellence with state of the art technology. Dr. Kenneth Davis, Mt. Sinai Health System president and CEO, provides insight into methods for diagnosing breast cancer.
March 4- Xoma Corp said it would not proceed with late-stage studies of its lead drug, gevokizumab, as a treatment for a form arthritis of the hand, after data from two mid-stage studies showed that the drug was not effective enough. Xoma said its analyses of the study did not show a significant drug-related benefit even after six months.
Several insurers, including Molina Healthcare, which administer health plans for California's Medicaid program for the poor are asking states to step in and pay for Gilead Sciences Inc's Sovaldi, a drug that costs $84,000 per patient.
The biotech drug lebrikizumab, which was developed by Roche Holding's Genentech unit, was tested at three doses in patients whose asthma was not sufficiently controlled even with high-dose, inhaled corticosteroids and a second asthma-controlling therapy.
Follow-up from an early-stage, 107- patient trial of the drug, Bristol-Myers Squibb's nivolumab, found that a year after treatment, 62 percent of patients were alive. F. Stephen Hodi, director of the Melanoma Treatment Center at Boston's Dana-Farber Cancer Institute and one of the study's senior authors.